REQUEST A DEMO
Total
USD $0.00
Search more companies

Yerlika Biopharma Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Yerlika Biopharma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Yerlika Biopharma Ilac A.S. is an enterprise located in Turkiye, with the main office in Istanbul. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on June 17, 2014. 80 (2025) employees currently work for Yerlika Biopharma Ilac A.S.. The latest financial highlights indicate a net sales revenue increase of 202.55% in 2023. A growth of 374.61% was recorded in its total assets.

Headquarters
G.tower A Bl.k:7 D:76 Barbaros Mahallesi Al Zambak S.varyap Merid.st Atasehir
Istanbul; Marmara; Postal Code: 34746

Contact Details: Purchase the Yerlika Biopharma Ilac A.S. report to view the information.

Website: http://www.yerlika.com

Basic Information
Total Employees:
Purchase the Yerlika Biopharma Ilac A.S. report to view the information.
Financial Auditors:
Purchase the Yerlika Biopharma Ilac A.S. report to view the information.
Incorporation Date:
June 17, 2014
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Yerlika Biopharma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
202.55%
Total operating revenue
202.55%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
374.61%
Total equity
751.37%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?